Chlamydia Trachomatis antibody

Catalog No. ABIN2859517

This Mouse Monoclonal antibody specifically detects Chlamydia Trachomatis in IF, EIA and IHC (p). It exhibits reactivity toward Chlamydia trachomatis and has been mentioned in 6+ publications.

Quick Overview for Chlamydia Trachomatis antibody (ABIN2859517)

Target: Chlamydia Trachomatis

Reactivity: Chlamydia trachomatis

Host: Mouse

Clonality: Monoclonal

Conjugate: This Chlamydia Trachomatis antibody is un-conjugated

Application: Immunofluorescence (IF), Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: BDI815

Product Details anti-Chlamydia Trachomatis Antibody

Purification: Protein A Chromatography

Immunogen: C. trachomatis LGV 2 elementary bodies.

Isotype: IgG1

Application Details

Application Notes: ELISA. IFA. Immunohistochemistry on paraffin sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 0.1mg/mL (OD280nm, E0.1% = 1.3)

Buffer: 0.01 M PBS, pH 7.2, 0.09 % Sodium Azide, None

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store the antibody at -20 °C. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Expiry Date: 12 months

References for anti-Chlamydia Trachomatis antibody (ABIN2859517)

Sanad, Jung, Kashoma, Zhang, Kassem, Saif, Rajashekara: "Insights into potential pathogenesis mechanisms associated with Campylobacter jejuni-induced abortion in ewes." in: BMC veterinary research, Vol. 10, pp. 274, (2016) (PubMed).

Hatayama, Ide: "Engineering of erythropoietin receptor for use as an affinity ligand." in: Protein expression and purification, Vol. 111, pp. 1-8, (2015) (PubMed).

Szatraj, Szczepankowska, Sączyńska, Florys, Gromadzka, Łepek, Płucienniczak, Szewczyk, Zagórski-Ostoja, Bardowski: "Expression of avian influenza haemagglutinin (H5) and chicken interleukin 2 (chIL-2) under control of the ptcB promoter in Lactococcus lactis." in: Acta biochimica Polonica, Vol. 61, Issue 3, pp. 609-14, (2014) (PubMed).

Scharek-Tedin, Pieper, Vahjen, Tedin, Neumann, Zentek: "Bacillus cereus var. Toyoi modulates the immune reaction and reduces the occurrence of diarrhea in piglets challenged with Salmonella Typhimurium DT104." in: Journal of animal science, Vol. 91, Issue 12, pp. 5696-704, (2014) (PubMed).

Martín-Villar, Fernández-Muñoz, Parsons, Yurrita, Megías, Pérez-Gómez, Jones, Quintanilla: "Podoplanin associates with CD44 to promote directional cell migration." in: Molecular biology of the cell, Vol. 21, Issue 24, pp. 4387-99, (2011) (PubMed).

Reimer, Phillips, Aloisio, Moore, Galland, Wells, Black, McDougal: "Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes." in: Hybridoma, Vol. 3, Issue 3, pp. 263-75, (1985) (PubMed).

Target Details for Chlamydia Trachomatis

Target: Chlamydia Trachomatis

Target Type: Bacteria

Background: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.